Murphy Pohlad Asset Management LLC Biogen Inc. Transaction History

Murphy Pohlad Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $1.32 Million - $1.98 Million	-5,566 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $611,618 - $706,190	-2,310 Reduced 29.33%	5,566 $1.58 Million
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $31,039 - $41,106	-120 Reduced 1.5%	7,876 $2.11 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $2.15 Million - $2.73 Million	7,996 New	7,996 $2.53 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.